Target type: biologicalprocess
The chemical reactions and pathways resulting in the breakdown of aldehydes, any organic compound with the formula R-CH=O. [GOC:ai]
Aldehyde catabolic process is a fundamental metabolic pathway that involves the breakdown of aldehydes, a class of organic molecules characterized by the presence of a carbonyl group (C=O) at the end of a carbon chain. This process is essential for various biological functions, including detoxification, energy production, and biosynthesis.
Aldehydes are generated from a variety of sources, including the breakdown of carbohydrates, lipids, and amino acids, as well as through metabolic reactions like oxidative stress. The catabolism of aldehydes typically involves the conversion of the carbonyl group into a hydroxyl group (-OH) by the action of specific enzymes called aldehyde dehydrogenases (ALDHs).
ALDHs are a superfamily of enzymes that catalyze the oxidation of aldehydes to carboxylic acids. This reaction requires NAD+ (nicotinamide adenine dinucleotide) as a cofactor, which is reduced to NADH during the process. Different ALDH isoforms exhibit substrate specificity and are responsible for the metabolism of specific aldehydes, playing crucial roles in various cellular processes.
The catabolic process of aldehydes is tightly regulated and involves a series of steps:
1. **Aldehyde oxidation:** The primary step involves the oxidation of the aldehyde to a carboxylic acid. This is catalyzed by ALDHs, which are highly specific for certain aldehyde substrates.
2. **Carboxylic acid metabolism:** The resulting carboxylic acids can undergo further metabolism, depending on their structure and the specific cellular context. They may be utilized as energy sources, incorporated into biosynthesis pathways, or excreted from the body.
3. **Regulation of aldehyde levels:** The catabolic process of aldehydes is tightly regulated to maintain cellular homeostasis and prevent the accumulation of toxic aldehydes. This regulation involves factors such as enzyme expression, substrate availability, and the activity of other metabolic pathways.
The aldehyde catabolic process is crucial for maintaining cellular health and preventing the accumulation of toxic byproducts. The breakdown of aldehydes through enzymatic oxidation is a critical step in detoxification, energy production, and biosynthesis. Dysregulation of this process can lead to various disorders, including neurological, cardiovascular, and developmental abnormalities.'
"
Protein | Definition | Taxonomy |
---|---|---|
Aldo-keto reductase family 1 member A1 | [no definition available] | Bos taurus (cattle) |
Aldo-keto reductase family 1 member A1 | An aldo-keto reductase family 1 member A1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P14550] | Homo sapiens (human) |
Aldehyde dehydrogenase, mitochondrial | An aldehyde dehydrogenase, mitochondrial that is encoded in the genome of human. [PRO:DNx, UniProtKB:P05091] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
zopolrestat | zopolrestat: structure given in first source | ||
disulfiram | organic disulfide; organosulfur acaricide | angiogenesis inhibitor; antineoplastic agent; apoptosis inducer; EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor; EC 3.1.1.1 (carboxylesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; EC 5.99.1.2 (DNA topoisomerase) inhibitor; ferroptosis inducer; fungicide; NF-kappaB inhibitor | |
valproic acid | valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem. Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS. | branched-chain fatty acid; branched-chain saturated fatty acid | anticonvulsant; antimanic drug; EC 3.5.1.98 (histone deacetylase) inhibitor; GABA agent; neuroprotective agent; psychotropic drug; teratogenic agent |
thiram | thiram : An organic disulfide that results from the formal oxidative dimerisation of N,N-dimethyldithiocarbamic acid. It is widely used as a fungicidal seed treatment. Thiram: A dithiocarbamate chemical, used commercially in the rubber processing industry and as a fungicide. In vivo studies indicate that it inactivates the enzyme GLUTATHIONE REDUCTASE. It has mutagenic activity and may induce chromosomal aberrations. | organic disulfide | antibacterial drug; antifungal agrochemical; antiseptic drug |
fr 74366 | |||
bis(1-piperidylthiocarbonyl)disulfide | bis(1-piperidylthiocarbonyl)disulfide: indicator for analysis of copper; structure | ||
win 18446 | WIN 18446 : A carboxamide that is 1,8-diaminooctane in which a hydrogen attached to each of the amino groups has been replaced by a dichloroacetyl group. Inhibitor of aldehyde dehydrogenase 1a2 (ALDH1a2). Inhibits the biosynthesis of retinoic acid from retinol in neonatal and adult murine testis. It down-regulates sex related genes in zebrafish. | organochlorine compound; secondary carboxamide | EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor |
tolrestat | tolrestat: RN & structure given in first source | naphthalenes | EC 1.1.1.21 (aldehyde reductase) inhibitor |
octyl gallate | gallate ester | food antioxidant; hypoglycemic agent; plant metabolite | |
4-(diethylamino)benzaldehyde | 4-(diethylamino)benzaldehyde : A member of the class of benzaldehydes carrying a diethylamino substituent at position 4. | aromatic amine; benzaldehydes; tertiary amino compound | EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor |
magnolol | biphenyls | ||
daidzin | daidzein 7-O-beta-D-glucoside : A glycosyloxyisoflavone that is daidzein attached to a beta-D-glucopyranosyl residue at position 7 via a glycosidic linkage. It is used in the treatment of alcohol dependency (antidipsotropic). daidzin: a potent, selective, and reversible inhibitor of human mitochondrial aldehyde dehydrogenase | 7-hydroxyisoflavones 7-O-beta-D-glucoside; hydroxyisoflavone; monosaccharide derivative | plant metabolite |
lidorestat | lidorestat: might prove useful in treating chronic diabetic complications; structure in first source | ||
fidarestat | fidarestat: structure given in first source | ||
minalrestat | minalrestat: a vasoactive agent | isoquinolines | |
sorbinil | sorbinil : An azaspiro compound having a monofluoro-substituted chromane skeleton spiro-linked to an imidazolidinedione ring. sorbinil: aldose reductase inhibitor | azaspiro compound; chromanes; imidazolidinone; organofluorine compound; oxaspiro compound | antioxidant; EC 1.1.1.21 (aldehyde reductase) inhibitor |
ononin | 4'-methoxyisoflavones; 7-hydroxyisoflavones 7-O-beta-D-glucoside; monosaccharide derivative | plant metabolite | |
7-butyl-8-[[4-(3-chlorophenyl)-1-piperazinyl]methyl]-1,3-dimethylpurine-2,6-dione | piperazines | ||
n-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide | N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide: Cardioprotective Agent; a small-molecule activator of aldehyde dehydrogenase-2 that reduces ischemic damage to the heart | carbonyl compound; organohalogen compound | |
epalrestat | epalrestat : A monocarboxylic acid that is 1,3-thiazolidine which is substituted on the nitrogen by a carboxymethyl group, at positions 2 and 4 by thioxo and oxo groups, respectively, and at position 5 by a 2-methyl-3-phenylprop-2-en-1-ylidene group. It is an inhibitor of aldose reductase (which catalyses the conversion of glucose to sorbitol) and is used for the treatment of some diabetic complications, including neuropathy. | monocarboxylic acid; thiazolidines | EC 1.1.1.21 (aldehyde reductase) inhibitor |
idd 594 | Idd 594: structure in first source | ||
daidzein | 7-hydroxyisoflavones | antineoplastic agent; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor; EC 3.2.1.20 (alpha-glucosidase) inhibitor; phytoestrogen; plant metabolite | |
caffeic acid phenethyl ester | phenethyl caffeate : An alkyl caffeate ester in which 2-phenylethyl is the alkyl component. | alkyl caffeate ester | anti-inflammatory agent; antibacterial agent; antineoplastic agent; antioxidant; antiviral agent; immunomodulator; metabolite; neuroprotective agent |
prunetin | prunetin : A hydroxyisoflavone that is genistein in which the hydroxy group at position 7 is replaced by a methoxy group. prunetin: reduces herpes virus-1 plaque formation | 7-methoxyisoflavones; hydroxyisoflavone | anti-inflammatory agent; EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor; EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor; metabolite |
4'-hydroxychalcone | 4'-hydroxychalcone : A member of the class of chalcones that is trans-chalcone substituted by a hydroxy group at position 4'. 4'-hydroxychalcone: inhibits TNFalpha-induced NF-κB activation; structure in first source | chalcones; phenols | anti-inflammatory agent; antineoplastic agent |